Literature DB >> 25420664

Evaluation of estimated number of influenza patients from national sentinel surveillance using the national database of electronic medical claims.

Yuuki Nakamura1, Tamie Sugawara, Hirokazu Kawanohara, Yasushi Ohkusa, Miwako Kamei, Kazunori Oishi.   

Abstract

Officially, the national official sentinel surveillance of infectious diseases (NOSSID) has been used to estimate the number of influenza patients nationwide; NOSSID is based on the Law Concerning the Prevention of Infectious Diseases and Medical Care for Patients of Infections (the Infectious Diseases Control Law). Prescription Surveillance (PS) has also provided a numerical estimate of influenza patients. This study compared these 2 estimations using NOSSID and PS with the numbers of influenza patients from all electronic medical claims (NDBEMC), which had the nearly-comprehensive data from surveys. Results showed that the estimate from NOSSID was about twice the estimate from the NDBEMC. However, the estimated number from the PS was almost equivalent to that from the NDBEMC. The estimated number of patients from NOSSID might not be precise, but NOSSID itself may be useful to monitor influenza trends.

Entities:  

Mesh:

Year:  2014        PMID: 25420664     DOI: 10.7883/yoken.JJID.2014.092

Source DB:  PubMed          Journal:  Jpn J Infect Dis        ISSN: 1344-6304            Impact factor:   1.362


  9 in total

1.  Measurement error and misclassification in electronic medical records: methods to mitigate bias.

Authors:  Jessica C Young; Mitchell M Conover; Michele Jonsson Funk
Journal:  Curr Epidemiol Rep       Date:  2018-09-10

2.  Evaluation of tooth loss among patients with diabetes mellitus using the National Database of Health Insurance Claims and Specific Health Checkups of Japan.

Authors:  Seitaro Suzuki; Tatsuya Noda; Yuichi Nishioka; Tomoaki Imamura; Hideyuki Kamijo; Naoki Sugihara
Journal:  Int Dent J       Date:  2020-02-26       Impact factor: 2.607

3.  Life-Threatening Abnormal Behavior Incidence in 10-19 Year Old Patients Administered Neuraminidase Inhibitors.

Authors:  Yuuki Nakamura; Tamie Sugawara; Yasushi Ohkusa; Kiyosu Taniguchi; Chiaki Miyazaki; Mariko Momoi; Nobuhiko Okabe
Journal:  PLoS One       Date:  2015-07-01       Impact factor: 3.240

4.  Estimated Number of Patients with Influenza A(H1)pdm09, or Other Viral Types, from 2010 to 2014 in Japan.

Authors:  Yoshitaka Murakami; Shuji Hashimoto; Miyuki Kawado; Akiko Ohta; Kiyosu Taniguchi; Tomimasa Sunagawa; Tamano Matsui; Masaki Nagai
Journal:  PLoS One       Date:  2016-01-19       Impact factor: 3.240

Review 5.  Japanese Surveillance Systems and Treatment for Influenza.

Authors:  Hassan Zaraket; Reiko Saito
Journal:  Curr Treat Options Infect Dis       Date:  2016-10-10

6.  Economic consequences of Japanese schools' recovery certificate policy for seasonal influenza.

Authors:  Shinya Tsuzuki
Journal:  BMC Public Health       Date:  2019-03-08       Impact factor: 3.295

7.  An Association of Influenza Epidemics in Children With Mobile App Data: Population-Based Observational Study in Osaka, Japan.

Authors:  Yusuke Katayama; Kosuke Kiyohara; Tomoya Hirose; Kenichiro Ishida; Jotaro Tachino; Shunichiro Nakao; Tomohiro Noda; Masahiro Ojima; Takeyuki Kiguchi; Tasuku Matsuyama; Tetsuhisa Kitamura
Journal:  JMIR Form Res       Date:  2022-02-10

8.  Adherence to dipeptidyl peptidase-4 inhibitor therapy among type 2 diabetes patients with employer-sponsored health insurance in Japan.

Authors:  Karen Kurtyka; Rie Nishikino; Chie Ito; Kim Brodovicz; Yong Chen; Kaan Tunceli
Journal:  J Diabetes Investig       Date:  2016-02-18       Impact factor: 4.232

9.  An Integrated Influenza Surveillance Framework Based on National Influenza-Like Illness Incidence and Multiple Hospital Electronic Medical Records for Early Prediction of Influenza Epidemics: Design and Evaluation.

Authors:  Cheng-Yi Yang; Ray-Jade Chen; Wan-Lin Chou; Yuarn-Jang Lee; Yu-Sheng Lo
Journal:  J Med Internet Res       Date:  2019-02-01       Impact factor: 5.428

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.